Skip to search boxSkip to navigationSkip to main content

Case report: Mucosal leishmaniasis presenting with nasal septum perforation after almost thirty years

  • ,
  • Universidad Continental, Huancayo
    ,
  • University of Virginia School of Medicine
    ,
  • Hospital Guillermo Almenara Irigoyen
    ,
  • Universidad Peruana Cayetano Heredia
Research Output:
Contribution to journal
Article
Peer-review

Open access

Publication Information

Output type

Research Output:
Contribution to journal
Article
Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 327-330 (4 pages)

Journal (Volume, Issue Number)

American Journal of Tropical Medicine and Hygiene (Volume 99, Issue 2)

Publication milestones

  • Published - 2018

Publication status

Published - 2018

ISSN

0002-9637

Publication IDs

  • Scopus: 85051076976
  • PubMed: 29869609

Abstract

Mucosal leishmaniasis (ML) is associated with progressive tissue destruction and granuloma formation, often after a considerable period of latency from an initial cutaneous infection. We report a case of recurrent epistaxis of 3 years duration and nasopharyngeal obstruction in a woman with treated cutaneous leishmaniasis nearly 30 years before and with no further exposure to Leishmania. Computed tomography revealed nasal septal perforation and histopathology demonstrated chronic inflammation. Microscopy was negative for amastigotes, but molecular testing of nasal mucosa biopsy detected Leishmania (Viannia) braziliensis. The patient underwent 28 days of treatment with IV sodium stibogluconate and her symptoms improved significantly. Sixteen months after treatment, she continues to have episodic epistaxis and detectable parasite load in her nasal lesion. Although ML is known to take years to decades to develop, there are few reported cases in the literature of such a long latency period. This report highlights the importance of considering ML in the differential diagnosis of chronic epistaxis in countries where leishmaniasis is endemic or in immigrants from these countries, even when presentation occurs decades after leaving an endemic region.

Funding Details

We thank Victor Rojas Figueroa, otolaryngologist at the Hospital Guillermo Almenara Irigoyen, and resident clinician Lisbeth Meza from the same service. We also thank Maxy de los Santos from the U.S. Naval Medical Research Unit No. 6 (NAMRU-6) in Lima, Peru for diagnostic support. Andres G. Lescano is sponsored by the training grant D43 TW007393 awarded by the Fogarty International Center of the US National Institutes of Health awarded to Emerge, the Emerging Diseases and Climate Change Research Unit of the School and Public Health Administration at Universidad Peruana Cayetano Heredia. Acknowledgments: We thank Victor Rojas Figueroa, otolaryngologist at the Hospital Guillermo Almenara Irigoyen, and resident clinician Lisbeth Meza from the same service. We also thank Maxy de los Santos from the U.S. Naval Medical Research Unit No. 6 (NAMRU-6) in Lima, Peru for diagnostic support. Andres G. Lescano is sponsored by the training grant D43 TW007393 awarded by the Fogarty International Center of the US National Institutes of Health awarded to Emerge, the Emerging Diseases and Climate Change Research Unit of the School and Public Health Administration at Universidad Peruana Cayetano Heredia.
FundersFunding numbers
School and Public Health Administration
-
Universidad Peruana Cayetano Heredia
-
NIH
-
FIC
D43TW007393
NIG
-

Publication metrics

Metrics

Scopus
Citations

PlumX, opens in new tab

Citations
4
Captures
25

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well